These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16084750)

  • 21. Enteral glutamine supplementation in critically ill patients with burn injuries: a retrospective case-control evaluation.
    Juang P; Fish DN; Jung R; MacLaren R
    Pharmacotherapy; 2007 Jan; 27(1):11-9. PubMed ID: 17192157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamine: do the data support the cause for glutamine supplementation in humans?
    Alpers DH
    Gastroenterology; 2006 Feb; 130(2 Suppl 1):S106-16. PubMed ID: 16473057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there a role for growth hormone therapy in refractory critical illness?
    Taylor BE; Buchman TG
    Curr Opin Crit Care; 2008 Aug; 14(4):438-44. PubMed ID: 18614909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of physical activity on glutamine metabolism.
    Agostini F; Biolo G
    Curr Opin Clin Nutr Metab Care; 2010 Jan; 13(1):58-64. PubMed ID: 19841583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring the clinical introduction of a glutamine and antioxidant solution in critically ill trauma and burn patients.
    Soguel L; Chioléro RL; Ruffieux C; Berger MM
    Nutrition; 2008; 24(11-12):1123-32. PubMed ID: 18692364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamine in critically ill patients: trial-sequential analysis.
    Maratea D; Fadda V; Trippoli S; Messori A
    Clin Nutr; 2014 Aug; 33(4):735-6. PubMed ID: 24582923
    [No Abstract]   [Full Text] [Related]  

  • 27. Practicalities of nutrition support in the intensive care unit.
    Davies AR
    Curr Opin Clin Nutr Metab Care; 2007 May; 10(3):284-90. PubMed ID: 17414496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutamine and antioxidants: status of their use in critical illness.
    van Zanten AR
    Curr Opin Clin Nutr Metab Care; 2015 Mar; 18(2):179-86. PubMed ID: 25590616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutamine supplementation in the critically ill: friend or foe?
    Oudemans-van Straaten HM; van Zanten AR
    Crit Care; 2014 May; 18(3):143. PubMed ID: 25032515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Have we enough glutamine and how does it work? A clinician's view.
    Soeters PB; Grecu I
    Ann Nutr Metab; 2012; 60(1):17-26. PubMed ID: 22212454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: bacterial translocation in the critically ill--evidence and methods of prevention.
    Gatt M; Reddy BS; MacFie J
    Aliment Pharmacol Ther; 2007 Apr; 25(7):741-57. PubMed ID: 17373913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comment on "Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients" by Tjäder et al.
    O'Leary MJ; Coakley JH
    Intensive Care Med; 2004 Sep; 30(9):1853. PubMed ID: 15232681
    [No Abstract]   [Full Text] [Related]  

  • 33. Direct molecular and spectroscopic evidence for increased ammonia removal capacity of skeletal muscle in acute liver failure.
    Chatauret N; Desjardins P; Zwingmann C; Rose C; Rao KV; Butterworth RF
    J Hepatol; 2006 Jun; 44(6):1083-8. PubMed ID: 16530878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of critically ill patients after supplementation with glutamine.
    Griffiths RD
    Nutrition; 1997; 13(7-8):752-4. PubMed ID: 9263282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of muscle protein and glutamine kinetics to branched-chain-enriched amino acids in intensive care patients after radical cancer surgery.
    Biolo G; De Cicco M; Dal Mas V; Lorenzon S; Antonione R; Ciocchi B; Barazzoni R; Zanetti M; Dore F; Guarnieri G
    Nutrition; 2006 May; 22(5):475-82. PubMed ID: 16472976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of glutamine in intensive care unit patients: mechanisms of action and clinical outcome.
    Coëffier M; Déchelotte P
    Nutr Rev; 2005 Feb; 63(2):65-9. PubMed ID: 15762090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutamine: mode of action in critical illness.
    Wischmeyer PE
    Crit Care Med; 2007 Sep; 35(9 Suppl):S541-4. PubMed ID: 17713406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutamine: Metabolism and Immune Function, Supplementation and Clinical Translation.
    Cruzat V; Macedo Rogero M; Noel Keane K; Curi R; Newsholme P
    Nutrients; 2018 Oct; 10(11):. PubMed ID: 30360490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutamine-enhanced nutrition in the critically ill patient.
    Andrews F; Griffiths R
    Hosp Med; 2002 Mar; 63(3):144-7. PubMed ID: 11933816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of nutrition to prevent stress-induced immunosuppression in the pediatric intensive care unit: a clinical trials minefield.
    Neu J
    JPEN J Parenter Enteral Nutr; 2009; 33(4):440-1. PubMed ID: 19407104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.